SEMA3C and neoplasm: These findings fit with the multiple reports indicating elevated expression of Sema3C in highly malignant human tumours and suggest the ability of tumour cells to switch Sema3C function from an anti-angiogenic to a growth-promoting one, by means of proteolytic processing.